Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Antiviral Res. 2015 Jul 29;122:39–45. doi: 10.1016/j.antiviral.2015.07.008

Figure 3.

Figure 3

NITD008 blocks WNV dissemination to peripheral tissues and brain. WNV-infected mice treated with vehicle or 10 mg/kg NITD008 on days 1–6 after inoculation were sacrificed at day 5 (spleen and kidney) and day 8 (brain) after infection and WNV titers were analyzed in the tissue homogenates using plaque assay. Dotted line- detection limit of plaque assay. Error bar represent ± SEM from at least 4 mice/group. *p<0.05